FIELD: biochemistry, enzymology. SUBSTANCE: method involves the use of the known compound - benzo-[1,2- -c:3,4-c']-bis-[1,2,5]-oxadiazole-1,6-dioxide of the formula (I) given in description of invention as a donor of nitrogen oxide and an activator of soluble guanylate cyclase. This compound exhibits the enhanced effectiveness as a donor of nitrogen oxide and shows more expressed activating effect on soluble guanylate cyclase as compared with its structural analog. The proposed compound can be used for study of regulatory effects of nitrogen oxide and mechanism of its action on soluble form of guanylate cyclase and other NO-depending enzymes. EFFECT: broadened pattern of nitrogen oxide donors and specific regulating agents of enzyme. 2 ex
Title | Year | Author | Number |
---|---|---|---|
DONOR OF NITROGEN OXIDE AND ACTIVATOR OF SOLUBLE FORM OF GUANYLATE CYCLASE | 1998 |
|
RU2139932C1 |
ACTIVATOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1997 |
|
RU2122582C1 |
SPECIFIC REGULATOR OF ACTIVITY OF NUCLEOTIDE-DEPENDENT ENZYMES | 1997 |
|
RU2130490C1 |
1,2,5-OXADIAZOLO[3,4-D]PYRIDAZINE-5,6-DIOXIDE DERIVATIVES AS ACTIVATORS OF SOLUBLE FORM OF GUANYLATE-CYCLASE AND AGENTS ACTIVE IN TREATMENT OF CENTRAL NERVOUS SYSTEM, AND COMPOSITIONS BASED ON THESE COMPOUNDS | 1997 |
|
RU2165256C2 |
INHIBITOR OF GUANYLATE CYCLASE SOLUBLE FORM | 1999 |
|
RU2151799C1 |
DERIVATIVES OF 1,4,2,5-DIOXADIAZINE | 2001 |
|
RU2212409C1 |
DONOR OF NITROGEN OXIDE ACTIVATING SOLUBLE FORM OF GUANYLATE CYCLASE, INHIBITING PLATELET AGGREGATION AND EXHIBITING SPASMOLYTIC AND VASODILATING EFFECT | 2001 |
|
RU2208438C1 |
INHIBITOR OF GUANYLATE CYCLASE SOLUBLE FORM | 2001 |
|
RU2196175C2 |
INHIBITOR OF NO-DEPENDENT ACTIVATION OF GUANYLATE CYCLASE SOLUBLE FORM | 2001 |
|
RU2188865C1 |
INHIBITOR OF NO-DEPENDENT ACTIVATION OF SOLUBLE FORM OF GUANYLATE CYCLASE | 2001 |
|
RU2189392C1 |
Authors
Dates
1998-12-10—Published
1997-12-26—Filed